case_images: PMC7582091_01
case_images: Histological findings of the liver biopsy specimen. (a) Moderate lymphocytic infiltrates in the portal areas of hepatic lobules with slightly piecemeal necrosis (hematoxylin and eosin staining; magnification, x40). (b) Fibrous expansion of portal areas with occasional portal-to-portal bridging (= F3 fibrosis) (Masson's trichrome staining; magnification, x40).
case_images: CRIHEP2020-8824974.001.jpg
case_images: PMC7582091_01_CRIHEP2020-8824974.001.jpg
case_images: fig1
case_images: CH-C with stage-3 (F3) fibrosis (Figure 1). Completion of this therapy resulted in a negative test for HCV-RNA, and the achievement of SVR was at the age of 56 years.
case_images: Contrast-enhanced CT showing the tumor (a) markedly enhanced in the arterial phase (b) followed by a relatively quick wash-out during the equilibrium phase (arrow).
case_images: CRIHEP2020-8824974.002.jpg
case_images: PMC7582091_01_CRIHEP2020-8824974.002.jpg
case_images: fig2
case_images: In the arterial phase of enhanced CT, the tumor was markedly enhanced, followed by a relatively quick wash-out in the equilibrium phase (Figure 2).
case_images: Time course of fibrosis-4 (FIB-4) index levels from SVR achievement to carcinogenesis.
case_images: CRIHEP2020-8824974.003.jpg
case_images: PMC7582091_01_CRIHEP2020-8824974.003.jpg
case_images: fig3
case_images: HCV-RNA remained negative; the hepatic steatosis was not observed by US and CT; the fibrosis-4 (FIB-4) index level dropped once, but gradually increased (Figure 3). He was admitted to our hospital for treatment.